D07.5
D07.5: Carcinoma in situ of prostate
Billable / specific codeICD-10-CM
D07.5 is a billable, specific ICD-10-CM code for carcinoma in situ of prostate. It is valid for submission on a claim.
Check D07.5 with the rest of the claim: free scrubberExcludes1: never code together
These conditions cannot occur together. Billing both on the same encounter is a denial.
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Prostatic intraepithelial neoplasia III (PIN III)
- Severe dysplasia of prostate
Other codes that can never be billed with D07.5
Their own Excludes1 notes name this code, so the conflict is not listed above.
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Medicare coverage
D07.5 is named in 17 Medicare coverage policies: 17 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A52453Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A54768Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic Chemotherapy
- A56421Billing and Coding: CT of the Abdomen and Pelvis
Alphabetic index entries that lead here
- Dysplasia›prostate›severe
- Neoplasia›intraepithelial›prostate›grade III(severe dysplasia)
Code history
Unchanged in every release from FY2024 to FY2027.